HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Connolly, C.K. Articles by Prescott, R.J. Search for Related Content PubMed PubMed Citation Articles by Connolly, C.K. Articles by Prescott, R.J.

The approach to the surgical management of cancer in four European countries

¹ Dept of Medicine, The Memorial Hospital, Darlington, UK, ² Dept of Thoracic and Vascular Surgery, University Hospital of Antwerp, Edegem, Belgium, ³ Dept of Respiratory Medicine, Stobhill Hospital, Glasgow, ⁴ Zurcher Hohenklinik Wald, Faltigberg, Switzerland and ⁵ Medical Statistics Unit, University of Edinburgh, Edinburgh, UK

CORRESPONDENCE: C.K. Connolly, Aldbrough House, Aldbrough St John, Richmond, North Yorkshire, DL11 7TP, UK. Fax: 44 1325374759. E-mail: ck-r.connolly@medix-uk.com

Keywords: europe, lung cancer, operability, questionnaire, respectability, UK

Received: May 12, 2003
Accepted May 19, 2003

This study was supported but not endorsed by a European Respiratory Society Task Force.

Abstract

Outcome of lung cancer appears poorer in the UK than elsewhere in Europe. This may be due to a less aggressive approach in treatment. This study investigated whether clinicians' perceptions of their approach differed between European countries.

A questionnaire was circulated to cancer specialists in four countries (Belgium, Greece, Switzerland and the UK) asking about management. An aggression score was calculated using the proportion of standard cases that would proceed to operation at different ages and levels of pulmonary function.

The principle problems suggested by most of the 314 respondents were inoperability before symptoms (particularly in the UK) and confounding effects of comorbidity. Surgeons particularly blamed delay in referral. The aggression scores (Belgium 54%, UK 49%, Switzerland 47% and Greece 37%) did not suggest the UK is an outlier, but the UK was more conservative in its approach to N2 disease and isolated cerebral metastasis. The aggression scores of surgeons were greater than those of the others (51% versus 42%).

Lung cancer was felt to present late with potentially confounding symptoms, but delay in the clinical process was thought to be less important. Although the UK was more conservative with special cases, its approach to typical cases could account for differences in patient survival.